Research & Innovation
Projects
The Institut de Recerca Sant Pau develops research projects across multiple scientific areas, with the aim of generating innovative knowledge that has an impact on health. Through national and international collaborations, these projects contribute to scientific progress and the improvement of healthcare.
International Grants Unit contact
Active
SLT041/25/000046
RACE+BIO: una eina basada en IA i biomarcadors per al triatge ràpid i precís de pacients amb ictus en l’àmbit prehospitalari
Start Date: 2025-12-04
End Date: 2026-12-03
Amount: 64.735,00 €
Funding body: DEPARTAMENT DE SALUT (GEN.CAT)
Call title: Proves de validació 2025
Active
PNC00431
Prognostic Value of Plasma p-Tau217 Levels Across Clinical Stages of Alzheimer's Disease: Real-World Data from Routine Clinical Practice in Spain
Start Date: 2025-12-04
End Date: 2026-12-04
Amount: 0,00 €
Active
BECA TRIENAL FMPJC 2025
Adjuvant chemotherapy in patients with CINSARC high-risk localized Uterine Leiomyosarcoma.
Start Date: 2025-12-02
End Date: 2028-12-31
Amount: 75.000,00 €
Funding body: FUNDACIÓN MARI PAZ JIMENEZ CASADO
Call title: 9ª BECA TRIENAL DE INVESTIGACIÓN EN SARCOMAS
Active
MBF-362CT-02
Estudio doble ciego controlado con placebo para evaluar la seguridad y la tolerabilidad de múltiples dosis orales de MBF-362 en mujeres premenopáusicas sanas y la eficacia preliminar en mujeres diagnosticadas con dismenorrea primaria moderada a severa
Start Date: 2025-12-01
End Date: 2027-01-31
Amount: 0,00 €
Active
PNC00423
Collab UPC_Able_SP_validacioo
Start Date: 2025-11-25
End Date: 2026-11-25
Amount: 0,00 €
Active
Acuerdo 180
Clinical impact of acetylcholinesterase inhibitors in the prodromal phases of neurodegenerative diseases: real-world clinical practice study with follow-up of up to 15 years (IIBSP-RIV-2025-127)
Start Date: 2025-11-10
End Date: 2026-11-10
Amount: 75.000,00 €
Funding body: ESTEVE PHARMACEUTICALS, S.A.
Active
E0400093
Epignètica del Càncer - Starting Package
Start Date: 2025-11-10
End Date: 2027-11-09
Amount: 0,00 €
Active
BECA BUESA 2025-1
Adjuvant chemotherapy in patients with CINSARC high-risk localized Uterine Leiomyosarcoma.
Start Date: 2025-11-04
End Date: 2027-10-09
Amount: 21.000,00 €
Funding body: GRUP.ESP.INVES.SARCOMAS-GEIS
Call title: 19ª Convocatoria de Beques José Mª Buesa 2025